Neogen Chemicals reported a 42% revenue increase to ₹296 crore in Q2 FY2027, but shares declined 3.5% after results missed market expectations. The company plans a ₹45 crore expansion to double organolithium capacity. Investors are now watching whether this investment can improve profitability amidst ongoing debt and interest cost concerns.
Neogen Chemicals saw its share price decline 3.5% to close at ₹2,095.40 on November 2, 2026, following the release of its second-quarter results for fiscal year 2027. While the company reported a notable 42% year-on-year rise in consolidated revenue to ₹296 crore, the figures fell slightly short of market expectations, leading to a cautious reaction from investors.
Despite the share price dip, the company is moving forward with aggressive expansion plans. Neogen announced a ₹45 crore capital investment to double its organolithium capacity at the Patancheru facility, increasing output from 300 metric tons per annum (MTPA) to 600 MTPA. This move is part of a broader strategy to capture demand in India’s growing battery chemical sector, where the company saw revenue reach ₹37 crore in the latest quarter. Management has set an ambitious standalone revenue target of over ₹1,100 crore for the full fiscal year 2027.
Balancing Growth and Financial Pressure
The company’s path to growth is being closely monitored due to its current financial position. While CRISIL recently revised the outlook on the company's long-term bank facilities and non-convertible debentures to 'Stable' from 'Negative'—a sign of improved confidence in its financial management—Neogen continues to face challenges from high debt and rising interest costs. These expenses have historically weighed on overall profitability.
Beyond debt levels, the company is dealing with operational complexities, including the need for careful management of working capital and inventory. Success in the current expansion phase will depend on how quickly and efficiently the new capacity at the Patancheru site can be brought online and utilized. Fluctuations in lithium prices and potential supply chain inflation also remain risks that could influence the company’s profit margins in the coming quarters.
What Investors Should Monitor
For the remainder of the fiscal year, investors are expected to track several key developments. First is the actual execution of the ₹45 crore capacity expansion. Any delay in project timelines could impact the company's ability to meet its revenue guidance. Second, the market will look for improvements in profit margins, specifically whether the company can successfully manage its interest burden as it scales up its battery chemicals business. Finally, management’s commentary on volume growth and price stability in the lithium salt market will be critical in determining whether the company can deliver on its long-term financial targets for fiscal year 2028.